Showing results (651-660 of 1,291) with videos related to

Sort By:
Pageof 130
Journal of Comparative Effectiveness Research|October 7, 2026
Bridging the gap in cell and gene therapy: addressing operational and financial barriers to achieve sustainable accessGary L Simmons, Robert E Richards, Ivan M Borrello, et al.
Journal of Comparative Effectiveness Research|August 31, 2026
Validation of an all-source composite mortality endpoint in the US populationYanina Natanzon, Lukas Slipski, Mark S Walker
Journal of Comparative Effectiveness Research|September 17, 2026
Rigorous, transparent and inconclusive: what Europe's first joint clinical assessment reveals about a framework trying to serve everyoneRamiro Gilardino, Antonella Cardone, Carlos M Cossio
Journal of Comparative Effectiveness Research|September 18, 2026
Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndromeEmmanuelle Kaltenbach, Alice Guiraud-Diawara, Jérémie Schwarzbard, et al.
Journal of Comparative Effectiveness Research|November 22, 2021
Factors impacting self-management ability in patients with chronic diseases in the United Arab Emirates, 2019Joel Ladner, Sawsan Alshurafa, Farah Madi, et al.
Journal of Comparative Effectiveness Research|November 9, 2021
Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end pointsErnest Law, Roya Gavanji, Sarah Walsh, et al.
Journal of Comparative Effectiveness Research|November 29, 2021
The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in DenmarkLars H Ehlers, Mark Lamotte, Mafalda C Ramos, et al.
Journal of Comparative Effectiveness Research|November 24, 2018
Validity and reliability of the Dundee difficult times of the day scale in Chinese children and adolescents with attention-deficit/hyperactivity disorderYasong Du, Yi Zheng, Xiaoyan Ke, et al.
Journal of Comparative Effectiveness Research|March 12, 2019
Impact of selective serotonin reuptake inhibitors in the veteran population: 10-year risk outcomesDaniel L Brinton, Annie N Simpson, Cory E Fominaya, et al.
Pageof 130